Maxcyte, Inc.
A maker of electroporation instruments and technology that help scientists slip genetic material like mRNA and DNA into living cells — a key step in building cell and gene therapies and vaccines. Its Flow Electroporation platform is used by biopharma companies and researchers to engineer cells for treating disease. Founded in 1999 in Gaithersburg, Maryland, the company's name blends "maximum" and "cyte" (the Greek root for cell), reflecting its goal of getting the most out of every engineered cell.
(b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries. As per the Announcement on 24 June 2026 (RNS Number: 4421J), the FCA has approved the change in control and proposed acquisition of River Global Holdings Limited. Subsequently, as of close of business on 31 July 2026, Liontrust Investment Partners (LIP) LLP assumed responsibility for the River Global Investors (RGI) LLP ICVC and ICAV funds. The relevant voting rights (approx 4.3%) attached to those holdings have therefore transferred from RGI LLP to LIP LLP. The remaining voting rights (approx 0.8%) continue to be held by RGI LLP and will be transferred at a later stage.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| RIVER GLOBAL INVESTORS LLP | 13DActivist | 0.8% | 834.1K | Aug 4, 2026 |
(b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries. As per the Announcement on 24 June 2026 (RNS Number: 4421J), the FCA has approved the change in control and proposed acquisition of River Global Holdings Limited. Subsequently, as of close of business on 31 July 2026, Liontrust Investment Partners (LIP) LLP assumed responsibility for the River Global Investors (RGI) LLP ICVC and ICAV funds. The relevant voting rights (approx 4.3%) attached to those holdings have therefore transferred from RGI LLP to LIP LLP. The remaining voting rights (approx 0.8%) continue to be held by RGI LLP and will be transferred at a later stage. | ||||
| BlackRock, Inc. | 13G/APassive | 1.3% | 1.40M | Jul 29, 2026 |
| Mirabella Financial Services LLP | 13G/APassive | 0% | 0 | Apr 10, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 27, 2026 |
| Cadian Capital Management, LP | 13G/APassive | 3.5% | 3.68M | Feb 17, 2026 |
| Cadian Capital Management GP, LLC | 13G/APassive | 3.5% | 3.68M | Feb 17, 2026 |
| ERIC BANNASCH | 13G/APassive | 3.5% | 3.68M | Feb 17, 2026 |
| Capricorn Fund Managers Ltd | 13GPassive | 7.7% | 8.20M | Feb 5, 2026 |